Literature DB >> 8390996

Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression.

B P Monia1, E A Lesnik, C Gonzalez, W F Lima, D McGee, C J Guinosso, A M Kawasaki, P D Cook, S M Freier.   

Abstract

We have used a previously described 17-mer phosphorothioate (Monia, B.P., Johnston, J.F., Ecker, D. J., Zounes, M.A., Lima, W.F., and Freier, S.M. (1992) J. Biol. Chem. 267, 19954-19962) for structure-function analysis of 2'-sugar modifications including 2'-O-methyl, 2'-O-propyl, 2'-O-pentyl, and 2'-fluoro. These modifications were analyzed for hybridization affinity to complementary RNA and for antisense activity against the Ha-ras oncogene in cells using a highly sensitive transactivation reporter gene system. Hybridization analysis demonstrated that all of the 2'-modified oligonucleotides hybridized with greater affinity to RNA than an unmodified 2'-deoxy oligonucleotide with the rank order of affinity being 2'-fluoro > 2'-O-methyl > 2'-O-propyl > 2'-O-pentyl > 2'-deoxy. Evaluation of antisense activities of uniformly 2'-modified oligonucleotides revealed that these compounds were completely ineffective in inhibiting Ha-ras gene expression. Activity was restored if the compound contained a stretch of at least five 2'-deoxy residues. This minimum deoxy length correlated perfectly with the minimum length required for efficient RNase H activation in vitro using partially purified mammalian RNase H enzyme. These chimeric 2'-modified/deoxy phosphorothioates displayed greater antisense potencies in inhibiting Ha-ras gene expression, compared with the unmodified uniform deoxy phosphorothioate. Furthermore, antisense potency correlated directly with affinity of a given 2' modification for it's complementary RNA. These results demonstrate the importance of target affinity in the action of antisense oligonucleotides and of RNase H as a mechanism by which these compounds exert their effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390996

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  155 in total

1.  Inhibition of IL-6 in mice by anti-NF-kappaB oligodeoxyribonucleotide N3'-->oligodeoxyribonnucleotide N3' --> P5' phosphoramidates.

Authors:  L Wang; S Gryaznov; M Nerenberg
Journal:  Inflammation       Date:  1999-12       Impact factor: 4.092

2.  Identifying ribozyme-accessible sites using NUH triplet-targeting gapmers.

Authors:  A A Mir; T J Lockett; P Hendry
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

3.  Synthesis and monitored selection of 5'-nucleobase-capped oligodeoxyribonucleotides.

Authors:  A A Mokhir; C Richert
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

4.  The experimental use of antisense oligonucleotides: a guide for the perplexed.

Authors:  C A Stein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

5.  2'-Deoxy-2'-fluoro-beta-D-arabinonucleosides and oligonucleotides (2'F-ANA): synthesis and physicochemical studies.

Authors:  C J Wilds; M J Damha
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

Review 6.  Preclinical and clinical pharmacology of antisense oligonucleotides.

Authors:  E G Marcusson; B R Yacyshyn; W R Shanahan; N M Dean
Journal:  Mol Biotechnol       Date:  1999-08       Impact factor: 2.695

7.  Independent combinatorial effect of antisense oligonucleotides and RNAi-mediated specific inhibition of the recombinant rat P2X3 receptor.

Authors:  Maja Hemmings-Mieszczak; Gabriele Dorn; François J Natt; Jonathan Hall; William L Wishart
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

8.  Potent and selective gene inhibition using antisense oligodeoxynucleotides.

Authors:  W M Flanagan; R W Wagner
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

9.  Hybridization of 2'-ribose modified mixed-sequence oligonucleotides: thermodynamic and kinetic studies.

Authors:  A Sabahi; J Guidry; G B Inamati; M Manoharan; P Wittung-Stafshede
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

10.  2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.

Authors:  Thazha P Prakash; Joseph F Johnston; Mark J Graham; Thomas P Condon; Muthiah Manoharan
Journal:  Nucleic Acids Res       Date:  2004-02-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.